cardiovascular risk in HIV

Tesamorelin for HIV Lipodystrophy Visceral Fat

Tesamorelin offers FDA-approved relief for HIV lipodystrophy by targeting visceral fat accumulation, the stubborn metabolic complication that increases cardiovascular risk and diminishes quality of life in long-term antiretroviral therapy patients.